These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 38305581)
1. Natural products as IL-6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Harmalkar DS; Sivaraman A; Nada H; Lee J; Kang H; Choi Y; Lee K Med Res Rev; 2024 Jul; 44(4):1683-1726. PubMed ID: 38305581 [TBL] [Abstract][Full Text] [Related]
2. Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular Docking. Nada H; Sivaraman A; Lu Q; Min K; Kim S; Goo JI; Choi Y; Lee K J Med Chem; 2023 Apr; 66(7):4417-4433. PubMed ID: 36971365 [TBL] [Abstract][Full Text] [Related]
3. A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors. Kaur S; Bansal Y; Kumar R; Bansal G Bioorg Med Chem; 2020 Mar; 28(5):115327. PubMed ID: 31992476 [TBL] [Abstract][Full Text] [Related]
4. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269 [TBL] [Abstract][Full Text] [Related]
5. Potential of natural products in inflammation: biological activities, structure-activity relationships, and mechanistic targets. Guo Y; Peng X; Liu F; Zhang Q; Ding L; Li G; Qiu F Arch Pharm Res; 2024 May; 47(5):377-409. PubMed ID: 38739203 [TBL] [Abstract][Full Text] [Related]
6. An insight into structure-activity relationship of naturally derived biological macromolecules for the treatment of Alzheimer's disease: a review. Halder D; Das S; Joseph A J Biomol Struct Dyn; 2024 Aug; 42(12):6455-6471. PubMed ID: 37378526 [TBL] [Abstract][Full Text] [Related]
7. TNF-α inhibitors with anti-oxidative stress activity from natural products. Li J; Zhang H; Huang W; Qian H; Li Y Curr Top Med Chem; 2012; 12(13):1408-21. PubMed ID: 22650374 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6: A Masterplayer in the Cytokine Network. Uciechowski P; Dempke WCM Oncology; 2020; 98(3):131-137. PubMed ID: 31958792 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Nishimoto N Clin Pharmacol Ther; 2010 Apr; 87(4):483-7. PubMed ID: 20182422 [TBL] [Abstract][Full Text] [Related]
11. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR. Meshram MA; Bhise UO; Makhal PN; Kaki VR Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of natural and synthetic lathyrane-based diterpenoids for suppression of NLRP3-driven inflammation and gouty arthritis. Zhuang Y; Pan B; Zhang Y; Tang Z; Ji X; Zhang S; Yao L; Li T; Ma W; Tan C; Luo Y Bioorg Chem; 2024 Sep; 150():107558. PubMed ID: 38878755 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 6: from bench to bedside. Nishimoto N; Kishimoto T Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory natural products as potential therapeutic agents of rheumatoid arthritis: A systematic review. Gandhi GR; Jothi G; Mohana T; Vasconcelos ABS; Montalvão MM; Hariharan G; Sridharan G; Kumar PM; Gurgel RQ; Li HB; Zhang J; Gan RY Phytomedicine; 2021 Dec; 93():153766. PubMed ID: 34624807 [TBL] [Abstract][Full Text] [Related]
15. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2). Abbas G; Al Harrasi A; Hussain H; Hamaed A; Supuran CT Bioorg Chem; 2019 May; 86():305-315. PubMed ID: 30738330 [TBL] [Abstract][Full Text] [Related]
16. A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential. Liu X; Li L; Wang Q; Jiang F; Zhang P; Guo F; Liu H; Huang J Front Immunol; 2021; 12():816646. PubMed ID: 35126375 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6: designing specific therapeutics for a complex cytokine. Garbers C; Heink S; Korn T; Rose-John S Nat Rev Drug Discov; 2018 Jun; 17(6):395-412. PubMed ID: 29725131 [TBL] [Abstract][Full Text] [Related]
18. From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Ridker PM Circ Res; 2016 Jan; 118(1):145-56. PubMed ID: 26837745 [TBL] [Abstract][Full Text] [Related]
19. Targeting interleukin-β by plant-derived natural products: Implications for the treatment of atherosclerotic cardiovascular disease. Vahdat-Lasemi F; Aghaee-Bakhtiari SH; Tasbandi A; Jaafari MR; Sahebkar A Phytother Res; 2021 Oct; 35(10):5596-5622. PubMed ID: 34390063 [TBL] [Abstract][Full Text] [Related]
20. An insight into anti-inflammatory effects of natural polysaccharides. Hou C; Chen L; Yang L; Ji X Int J Biol Macromol; 2020 Jun; 153():248-255. PubMed ID: 32114173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]